VCI Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,008
Closed -$2.74M 124
2025
Q4
$2.74M Buy
+12,008
New +$2.74M 0.76% 31
2025
Q3
Sell
-9,028
Closed -$1.68M 116
2025
Q2
$1.68M Buy
9,028
+1,414
+19% +$263K 0.59% 41
2025
Q1
$1.6M Buy
+7,614
New +$1.48M 0.67% 34

Other funds holding ABBV

VCI Wealth Management's ABBV Position: Q1 2026 in Review

VCI Wealth Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 12,008 shares — an estimated $2.74M sold.

VCI Wealth Management first reported a position in ABBV in Q1 2025 and held it in 3 quarters. The position peaked at $2.74M in Q4 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • VCI Wealth Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • VCI Wealth Management sold 12,008 AbbVie shares in Q1 2026, an estimated $2.74M.
  • VCI Wealth Management first reported a position in AbbVie in Q1 2025 and held it in 3 quarters.
  • VCI Wealth Management's AbbVie position peaked at $2.74M in Q4 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on VCI Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.